Unknown Primary Cancer
📧 Sign up to get email alerts when something new happens for Unknown Primary Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP) [Phase 2]
A phase 2 trial evaluating nab-paclitaxel-based doublet as first-line therapy for cancer of unknown primary (unknown primary tumors).
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
This completed clinical trial update reviews the use of real-time PCR-based molecular profiling in unknown primary cancer.